1 / 10

Photodynamic Therapy Market Forecast 2022-2029

By type, the photodynamic therapy market is dominated by photosensitizer drugs due to negligible toxicity and the ability to produce reactive oxygen species to promote cell death in tumors. The third-generation photosensitizers, used for targeted cell destruction topically and intravenously, are available for the treatment of skin and eye disorders.

Prathibha3
Download Presentation

Photodynamic Therapy Market Forecast 2022-2029

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Photodynamic Therapy Market|2022-2029 Photodynamic Therapy Market is segmented by Product Type (Photosensitizer Drugs, Laser Devices), By Application (Oncology, Dermatology, Ophthalmology and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2022-2029 Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  2. Photodynamic Therapy Market|2022-2029 Overview: Photodynamic Therapy Market is a type of treatment that use medications and equipment to treat chronic conditions such as cancer and malignant musculoskeletal tumours. Novel light-emitting devices are gaining interest in the treatment of actinic keratosis. Companies in the photodynamic therapy business are gaining market share through inorganic techniques such as label extensions. However, PDT encounters widespread challenges in the treatment of drug-resistant breast cancer, such as blood artery obstruction, collapse, and eventual vascular shutdown. The rise in the frequency of skin disorders and cancer, as well as the rise in demand for minimally invasive procedures, are likely to drive the worldwide photodynamic therapy market. The approval of innovative biologics by regulatory bodies in both developed and developing nations has given patients more treatment options. Browse for Our Full report @ https://www.datamintelligence.com/research-report/photodynamic-therapy- pdt-market Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  3. Photodynamic Therapy Market|2022-2029 Market Growth and Future Apprehension: The most recent DataM Intelligence report predicted that the worldwide "Photodynamic Therapy Market" will expand at a high CAGR 6% during 2022 to 2029. Market Dynamics: Drivers: The growing prevalence of skin cancer internationally is driving the global market for photodynamic treatment. For example, it is expected that approximately 891 thousand new cancer cases would be detected among women in the United States in 2019, with the number of new melanoma cases diagnosed increasing by 7.7 percent. . Restraints: However, the high cost of photodynamic therapy, as well as a lack of knowledge and problems connected with IVF treatment, are some of the reasons limiting the growth of the photodynamic therapy market. Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  4. Photodynamic Therapy Market|2022-2029 Recent Developments: ✓ Lumeda, Inc., a medical technology startup developing photodynamic therapy (PDT) as intraoperative adjuvant treatment for patients undergoing lung cancer surgery, announced the completion of its Series A investment round in April 2021. ✓ In May 2020, Theralase Technologies, Inc., a company specializing in the research and development of light- activated photodynamic compounds (PDC) and their associated drug formulations to safely and effectively destroy various cancers, received FDA Investigational New Drug (IND) approval to conduct a phase II non-muscle invasive bladder cancer (NMIBC) clinical study (study II) in the United States. Browse For Our Free Sample Request Report @ https://www.datamintelligence.com/download- sample/photodynamic-therapy-pdt-market Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  5. Photodynamic Therapy Market|2022-2029 Regional Analysis: North America is expected to hold the largest share of the global photodynamic therapy market during the forecast period, owing to the presence of key players in the country, an increase in demand for new biologics for cancer treatment, a high rate of photodynamic therapy adoption, and new product launches by market players. Increased FDA product approvals, increased use of photodynamic therapy for the treatment and management of actinic keratosis, and an increase in the number of cosmetologists delivering photodynamic therapy are driving the photodynamic therapy market in North America Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  6. Photodynamic Therapy Market|2022-2029 Photodynamic Therapy Market Segmentation Analysis: By Product: By Application: • • Photosensitizer Drugs Laser Devices Oncology Dermatology Ophthalmology • • • Others • Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  7. Photodynamic Therapy Market|2022-2029 Competitive Landscape: Some of the prominent players in the global Photodynamic Therapy Market are • • • • • • • • • Allergan plc Lumenis Ltd PhotoMedex Valeant Pharmaceuticals International, Inc Galderma SA Biofrontera AG Dusa Pharmaceuticals Quest Pharmatech, Inc Biolitec AG Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  8. Photodynamic Therapy Market|2022-2029 Major Countries Focused: Major Countries Focused: Geographical Classification Geographical Classification • • • • • North America Europe South America Asia Pacific Middle East and Africa • • • • • • • • • • • United States Canada Brazil Spain Italy United Kingdom South Korea Russia China Japan Rest of the Countries Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  9. || About Us || DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world. We monitor and analyze the market by dissecting various market influencers, competitive intensity, innovations, trends, and emerging products. This aids us in providing a detailed scenario of the present and future of the market. Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

  10. || Contact Us || Contact Us: Sai Kiran DataM Intelligence 4Market Research LLP +1 877–441–4866 info@datamintelligence.com Follow Us on Copy Right: DataM Intelligence 4Market Research info@datamintelligence.com

More Related